Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Comparative efficacy and safety of monoclonal...
Journal article

Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis

Abstract

BACKGROUND: Chronic rhinosinusitis with nasal polyposis (CRSwNP) is an inflammatory condition of the upper airways. Optimal management is unclear. OBJECTIVE: We compared the effects of mAbs and aspirin desensitization (ASA-D) for treatment of CRSwNP.

Authors

Oykhman P; Paramo FA; Bousquet J; Kennedy DW; Brignardello-Petersen R; Chu DK

Journal

The Journal of Allergy and Clinical Immunology, Vol. 149, No. 4, pp. 1286–1295

Publisher

Elsevier

Publication Date

4 2022

DOI

10.1016/j.jaci.2021.09.009

ISSN

0091-6749